PIM-3 as A Potential Drug Target and Biomarker (G415116)
PIM-3 as A Potential Drug Target and Biomarker
Pim-3 (also known as PIM3) is a protein that is expressed in various tissues of the body, including the brain, heart, liver, and kidneys. It is a member of the Pim gene family, which is known for its role in regulating signaling pathways that are involved in a wide range of cellular processes. While the exact function of Pim-3 is not yet fully understood, it is clear that it plays an important role in several physiological processes that are critical for human health.
The Pim gene family has been identified as a potential drug target in several diseases, including neurodegenerative disorders, autoimmune diseases, and reproductive disorders. Pim-3 is one of the most well-studied Pim gene products, and there is growing interest in its potential as a drug target.
Disease association with Pim-3
Several studies have suggested that Pim-3 may be involved in the development and progression of several diseases. For example, studies have shown that individuals with certain genetic mutations, such as those in the PIM3 gene, are at increased risk for developing neurodegenerative disorders, such as Alzheimer's disease and Parkinson's disease.
In addition, Pim-3 has also been implicated in several autoimmune diseases, including type 1 diabetes and rheumatoid arthritis. These diseases are characterized by the immune system attacking the body's own tissues, and Pim-3 has been shown to play a role in the regulation of immune responses.
Furthermore, there is also evidence to suggest that Pim-3 may be involved in the development of reproductive disorders. For example, studies have shown that individuals with certain genetic mutations, such as those in the PIM3 gene, are at increased risk for developing infertility and other reproductive disorders.
Pim-3 as a drug target
The potential use of Pim-3 as a drug target is based on several factors. Firstly, Pim-3 is a protein that is expressed in a wide range of tissues, making it an attractive target for drugs that can be administered to a variety of different cells. Secondly, Pim-3 is involved in several important physiological processes that are critical for human health, which makes it an attractive target for drugs that can modulate these processes.
One of the most promising aspects of Pim-3 as a drug target is its involvement in the regulation of signaling pathways that are involved in a wide range of cellular processes. For example, Pim-3 has been shown to play a role in the regulation of cell growth, differentiation, and survival.
In addition, Pim-3 is also involved in the regulation of the immune system, which is a critical system that helps the body fight off infections and diseases. This suggests that Pim-3 may be a useful target for drugs that can modulate the immune system and improve its function.
Another potential mechanism by which Pim-3 may be targeted as a drug is its role in the regulation of cell-cell interactions. Studies have shown that Pim-3 plays a role in the regulation of cell-cell adhesion, which is critical for the maintenance of tissue structure and function. This suggests that Pim-3 may be a useful target for drugs that can modulate cell-cell interactions and improve tissue structure and function.
Pim-3 as a biomarker
Pim-3 may also be used as a biomarker in the diagnosis and monitoring of several diseases. For example, Pim-3 has been shown to be expressed in the brains of individuals with Alzheimer's disease, and levels of Pim-3 have been shown to be decreased in the brains of individuals with Alzheimer's disease compared to age-matched controls. This suggests that Pim-3 may be a useful biomarker for the diagnosis and monitoring of Alzheimer's disease.
In addition, Pim-3 has also been shown to be expressed in the blood vessels of individuals with type 1 diabetes, and levels of Pim-3 have been shown to be increased in the blood vessels of individuals with type 1 diabetes compared to healthy individuals. This suggests that Pim-3 may be a useful biomarker for the diagnosis and monitoring of
Protein Name: Pim-3 Proto-oncogene, Serine/threonine Kinase
Functions: Proto-oncogene with serine/threonine kinase activity that can prevent apoptosis, promote cell survival and protein translation. May contribute to tumorigenesis through: the delivery of survival signaling through phosphorylation of BAD which induces release of the anti-apoptotic protein Bcl-X(L), the regulation of cell cycle progression, protein synthesis and by regulation of MYC transcriptional activity. Additionally to this role on tumorigenesis, can also negatively regulate insulin secretion by inhibiting the activation of MAPK1/3 (ERK1/2), through SOCS6. Involved also in the control of energy metabolism and regulation of AMPK activity in modulating MYC and PPARGC1A protein levels and cell growth
More Common Targets
PIMREG | PIN1 | PIN1-DT | PIN1P1 | PIN4 | PINCR | PINK1 | PINK1-AS | PINLYP | PINX1 | PIP | PIP4K2A | PIP4K2B | PIP4K2C | PIP4P1 | PIP4P2 | PIP5K1A | PIP5K1B | PIP5K1C | PIP5K1P1 | PIP5KL1 | PIPOX | PIPSL | PIR | PIR-FIGF | PIRAT1 | PIRT | PISD | PISRT1 | PITHD1 | PITPNA | PITPNA-AS1 | PITPNB | PITPNC1 | PITPNM1 | PITPNM2 | PITPNM2-AS1 | PITPNM3 | PITRM1 | PITRM1-AS1 | PITX1 | PITX1-AS1 | PITX2 | PITX3 | PIWIL1 | PIWIL2 | PIWIL2-DT | PIWIL3 | PIWIL4 | PIWIL4-AS1 | PJA1 | PJA2 | PJVK | PKD1 | PKD1-AS1 | PKD1L1 | PKD1L1-AS1 | PKD1L2 | PKD1L3 | PKD1P1 | PKD1P4-NPIPA8 | PKD1P6 | PKD2 | PKD2L1 | PKD2L2 | PKD2L2-DT | PKDCC | PKDREJ | PKHD1 | PKHD1L1 | PKIA | PKIA-AS1 | PKIB | PKIG | PKLR | PKM | PKMP1 | PKMYT1 | PKN1 | PKN2 | PKN2-AS1 | PKN3 | PKNOX1 | PKNOX2 | PKNOX2-DT | PKP1 | PKP2 | PKP3 | PKP4 | PKP4-AS1 | PLA1A | PLA2G10 | PLA2G12A | PLA2G12AP1 | PLA2G12B | PLA2G15 | PLA2G1B | PLA2G2A | PLA2G2C | PLA2G2D